Are you sure you want to leave?
12 June 2020
Adapting to the state of lockdown imposed by COVID-19, the 2020 European Renal Association–European Dialysis and Transplant Association (ERA–EDTA) Congress went online. We were there to raise awareness about secondary hyperparathyroidism (SHPT) and chronic kidney disease–mineral and bone disorder (CKD–MBD) by running a virtual symposium and hosting a virtual booth. Access to online videos of the symposium and highlights about the booth are provided below.
Watch the teaser video now. For the full-length presentations, please see the link below.
Our symposium, which was entitled ‘Expert approaches to management across the CKD–MBD continuum’, gave attendees the opportunity to explore the latest expert opinions on managing SHPT in non-dialysis patients and controlling hyperphosphataemia in dialysis patients.
The symposium was chaired by Dr Smeeta Sinha* and included two presentations:
If you missed the symposium, you can watch it online right now.
Our virtual booth was divided into three sections, raising awareness about:
The SHPT section of the booth provided access to many of the features available on this website, allowing attendees to:
We’d like to extend our gratitude to all involved in delivering our booth and symposium, especially the Chair, Dr Sinha, and our distinguished speakers, professors Cozzolino and Kalantar-Zadeh.
*North West England Renal Network Chair; National Health Service; Manchester, United Kingdom.
†Director of Renal Unit and Laboratory of Experimental Nephrology; Department of Health Sciences, University of Milan; Milan, Italy.
‡Professor of Medicine; School of Medicine, University of California, Irvine; California, USA.
You are viewing a website from Vifor Pharma. This material is only intended for healthcare professionals (“HCPs”) from Europe. If you are not the intended audience, please leave this website. By checking the box, you acknowledge that you are a HCP from Europe. Approval conditions for products may vary from country to country. Before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.
I am residing in:
Bitte verwenden Sie als Benutzernamen die E-Mail Adresse, welche Sie bei der Registration angegeben hatten. Falls Sie das Passwort vergessen haben, können Sie sich einen Reaktivierungslink zustellen lassen. Alternativ ist für bereits registrierte Health Professionals auch eine Anmeldung mit der HPC-Card von FMH oder pharmaSuisse möglich.